Dacarbazine-encapsulated solid lipid nanoparticles for skin cancer: physical characterization, stability, in-vivo activity, histopathology, and immunohistochemistry

BACKGROUND: This study examined the use of solid lipid nanoparticles (SLNs) to administer Dacarbazine (DTIC) to skin melanoma cells with minimal adverse effects. Melanoma is a tricky skin cancer to cure, and standard chemotherapy has many negative effects. Encapsulating DTIC in SLNs may allow the dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhattacharya, Sankha, Sharma, Satyam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160449/
https://www.ncbi.nlm.nih.gov/pubmed/37152046
http://dx.doi.org/10.3389/fonc.2023.1102269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160449/
https://www.ncbi.nlm.nih.gov/pubmed/37152046
http://dx.doi.org/10.3389/fonc.2023.1102269

Ejemplares similares